Press release
Tinea Versicolor treatment Market 2018 | Major Leading Players Astellas Pharma US, Inc., Bayer AG, Enzon Pharmaceuticals, Inc. , Galderma S.A. , Gilead , Novartis AG - |Forecast 2023
Market Research Future Present’s “Global Tinea Versicolor Treatment Market Size, Status and Forecast 2022” magnify the decision making potentiality and helps to create an effective counter strategies to gain competitive advantage. The report provides an extensive research and detailed analysis of the present market along with future outlook.Tinea Versicolor Treatment Market -Overview
Tinea Versicolor is one of the common types of skin infection. It also called as pityriasis versicolor. In this condition, small and discolored patches of skin occur, mostly affecting the shoulders and trunk.
Increasing prevalence of tinea versicolor, increasing awareness of the disease, rising healthcare expenditure, advanced diagnosis and treatment options, and approval of new antifungal medicines are leading the growth of global tinea versicolor treatment market.
Global tinea versicolor treatment market is expected to grow at the CAGR of ~7.1% during the forecast period and is estimated to reach USD 197.9 million by 2023.
Tinea Versicolor Treatment Market -Market Segments
Global tinea versicolor treatment market has been segmented on the basis of diagnosis which comprise physical exam, imaging tests, and others. Imaging test is sub-segmented into wood lamp (black light) examination, microscopy using potassium hydroxide (KOH), fungal culture, skin biopsy, and others. Skin biopsy is sub-segmented into shave biopsy, punch biopsy, excisional biopsy, and others.
On the basis of treatments, the market has been segmented into antifungal shampoos, antifungal creams, drugs, and others. Antifungal shampoos are sub-segmented into selenium sulfide (selsun) 2.5 percent shampoo, ciclopirox (loprox, penlac) shampoo, ketoconazole (ketoconazole, nizoral, others) shampoo, and others.
Antifungal creams are sub-segmented into Selenium sulfide (Selsun) 2.5 percent lotion, Ciclopirox (Loprox, Penlac) cream or gel, Ketoconazole (Ketoconazole, Nizoral, others) cream or gel, and others. Drugs are further sub-segmented into fluconazole (diflucan) tablets or oral solution, and others.
Get PDF with Technological Advancement @ https://www.marketresearchfuture.com/sample_request/3878
Tinea Versicolor Treatment Market -Key developments
Major players in the market are engaged in the development of new products to capture the market globally. Thus, key market players are investing more in research and development activity, in order to lead the global market. In this regards, market players undertake various strategic approaches.
In March 2016, Novartis cancer drug gets FDA's principal 'biosimilar' affirmation. Federal regulators have permitted the first “biosimilar” drug to be sold in the U.S. under a program intended to branch a new market of lower-cost substitutes to some of the most expensive treatments in healthcare.
In May 2016, Novartis studies new sales model for tentative cancer therapy. Novartis strategies to use a medical device-like sales model to market its CAR T-cell technology if the new cancer treatment receives FDA approval.
Tinea Versicolor Treatment Market -Regional Analysis
Considering the global scenario of the market, America is the top contributor in this market. The Americas mainly include North America and South America. Due to large amount of money invested in research, clinical trials, and new product development, US is the dominating country in this region. Europe is the second largest market for tinea versicolor treatment.
Germany is dominating this market while UK is the fastest growing tinea versicolor treatment market. Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly improving healthcare facilities, increasing awareness of disease, and rising healthcare expenditure. Middle East & Africa is expected to have limited growth.
Obtain Report Details with Technological Advancement @ https://www.marketresearchfuture.com/reports/tinea-versicolor-treatment-market-3878
Tinea Versicolor Treatment Market -Key Players
Astellas Pharma US, Inc. (Japan)
Bayer AG (German)
Enzon Pharmaceuticals, Inc. (US)
Galderma S.A. (Switzerland)
Gilead (US)
Novartis AG (Switzerland)
Pfizer Inc. (US)
Taro Pharmaceutical Industries Ltd. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Valeant (Canada)
Major Points form TOC for Tinea Versicolor Treatment Market Research Report – Forecast to 2023
Chapter 1. Report Prologue
Chapter 2. Market Introduction
Chapter 3. Research Methodology
Chapter 4. Market Dynamics
Chapter 5. Market Factor Analysis
Chapter 6. Global Tinea Versicolor Treatment Market, By Type
Chapter 7. Global Tinea Versicolor Treatment Market, By Treatment
Chapter 8 Global Tinea Versicolor Treatment Market, By End User
Chapter 9. Global Tinea Versicolor Treatment Market, By Region
Chapter 10. Company Landscape
Chapter 11. Company Profiles
Chapter 12. MRFR Conclusion
Chapter 13. Appendix
GetExcusiveDiscount@https://www.marketresearchfuture.com/check-discount/3878
About US:
Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
Contact Us:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune - 411028
Maharashtra, India
Phone: +1 646 845 9312
Email: sales@marketresearchfuture.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Tinea Versicolor treatment Market 2018 | Major Leading Players Astellas Pharma US, Inc., Bayer AG, Enzon Pharmaceuticals, Inc. , Galderma S.A. , Gilead , Novartis AG - |Forecast 2023 here
News-ID: 1224988 • Views: …
More Releases from Market Research Future
UAE Power EPC Market Growth Analysis: From USD 3.94 Billion in 2024 to USD 6.31 …
The UAE Power EPC (Engineering, Procurement, and Construction) market plays a critical role in supporting the country's rapidly evolving energy landscape. As the UAE continues to balance economic growth, population expansion, and sustainability goals, the demand for reliable and efficient power infrastructure has intensified. Power EPC projects act as the backbone of this transformation by enabling the planning, development, and execution of power generation, transmission, and distribution facilities across the…
Orthobiologics Market to Reach USD 13.2 Billion by 2035, Expanding at 6.2% CAGR …
Orthobiologics Market Overview and Market Size
The positive market forecast reflects strong demand for biologics that enhance healing and improve functional outcomes in orthopedic care. Increasing focus on patient-centric treatment pathways and cost optimization continues to define the market global outlook.
As per MRFR analysis, the Orthobiologics Market Size was estimated at 7.2 USD Billion in 2025. The Orthobiologics industry is projected to grow from 7.7 USD Billion in 2026 to 13.2…
Healthcare Regulatory Affairs Outsourcing Market to Reach USD 14.55 Billion by 2 …
Healthcare Regulatory Affairs Outsourcing Market Overview and Market Sizing
This robust market growth is indicative of the critical role outsourcing plays in helping healthcare organizations manage regulatory risk, improve time-to-market, and contain operational costs amid evolving global standards.
As per Market Research Future analysis, the Healthcare Regulatory Affairs Outsourcing Market was estimated at 6.12 USD Billion in 2024. The Healthcare Regulatory Affairs Outsourcing industry is projected to grow from 6.621 USD…
Drug Discovery Informatics Market Poised to Grow from USD 3.8 Billion in 2024 to …
Drug Discovery Informatics Market Overview and Market Size
The Drug Discovery Informatics Market is advancing rapidly as pharmaceutical and biotechnology companies adopt digital and data-driven solutions to accelerate therapeutic discovery.
As per Market Research Future analysis, the Drug Discovery Informatics Market Size was estimated at 3.8 USD Billion in 2024. The Drug Discovery Informatics industry is projected to grow from 4.158 USD Billion in 2025 to 10.21 USD Billion by 2035,…
More Releases for Tinea
Foot & Ankle Injuries Fueling Tinea Pedis Market Growth: Pivotal Factor Influenc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Tinea Pedis Treatment Market Size Growth Forecast: What to Expect by 2025?
In recent times, the tinea pedis treatment market has seen robust growth. The market is projected to increase from $1.36 billion in 2024 to $1.45 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%.…
Tinea Corporis Market New Product Development & Latest Trends
Tinea Corporis market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Tinea Corporis Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as…
Global Onychomycosis (Tinea Unguium) Drug Market
Onychomycosis (Tinea Unguium) Drug Market Forecast 2020-2026
The Global Onychomycosis (Tinea Unguium) Drug Market research report provides and in-depth analysis on industry- and economy-wide database for business management that could potentially offer development and profitability for players in this market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes…
Tinea Corporis Drugs Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Tinea Corporis Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Tinea Corporis Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Tinea Corporis Drugs with respect…
Tinea Pedis Treatment Market Dynamic Business Environment during 2017 - 2025
Global Tinea Pedis Treatment Market: Snapshot
Athlete's foot known medically as tinea pedis, is a common skin infection of the feet caused by various kinds of fungi. Signs and symptoms often include itching, scaling, cracking and redness. In rare cases, the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the toes. Apart from these areas, the fungus might develop at the…
Tinea Pedis Treatment Market 2017- GSK, Exeltis USA, Valeant
Marketreports.biz, recently published a detailed market research study focused on the "Tinea Pedis Treatment Market" across the global, regional and country level. The report provides 360° analysis of "Tinea Pedis Treatment Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Tinea Pedis Treatment industry, and estimates the future trend of Tinea…
